Amgen AMGN
NASDAQ AMGN
$465.67 -1.39 (-0.30%)
At close: Nov 13, 2026 · 4:00 PM EST

Amgen (AMGN) Non Operating Interest Expenses (2009 - 2026)

Updated

Amgen's Non Operating Interest Expenses was $653 million in Q3 2026, down 4.7% from $685 million a year earlier and down 3.0% from the prior quarter.

Analysis

Amgen (AMGN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amgen's Non Operating Interest Expenses was $2.64 billion through Sep 30, 2026, down 7.5% year-over-year; for FY2025, it came in at $2.76 billion, down 12.7% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 16.9% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $3.16 billion in FY2024 (+9.7%), $2.88 billion in FY2023 (+104.5%), $1.41 billion in FY2022 (+17.5%) and $1.2 billion in FY2021 (-5.2%).
  • Quarterly Non Operating Interest Expenses has moved between $295 million (Q1 2022) and $824 million (Q1 2024) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for eight straight quarters, with an average decline of 9.6% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 129.3%); the worst was Q2 2025 (a decline of 14.1%).
  • Per Business Quant data, AMGN's Non Operating Interest Expenses in the three quarters before Q3 2026 was $673 million (Q2 2026), $657 million (Q1 2026) and $653 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 217.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn 36.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 653.00 Mn
Jun 30, 2026 673.00 Mn
Mar 31, 2026 657.00 Mn
Dec 31, 2025 653.00 Mn
Sep 30, 2025 685.00 Mn
Jun 30, 2025 694.00 Mn
Mar 31, 2025 723.00 Mn
Dec 31, 2024 747.00 Mn
Sep 30, 2024 776.00 Mn
Jun 30, 2024 808.00 Mn
Mar 31, 2024 824.00 Mn
Dec 31, 2023 821.00 Mn
Sep 30, 2023 759.00 Mn
Jun 30, 2023 752.00 Mn
Mar 31, 2023 543.00 Mn
Dec 31, 2022 415.00 Mn
Sep 30, 2022 368.00 Mn
Jun 30, 2022 328.00 Mn
Mar 31, 2022 295.00 Mn
Dec 31, 2021 335.00 Mn
API Access

Amgen Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AMGN&period=max&api_key=YOUR_API_KEY